A comprehensive view of Bristol-Myers Squibb Co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

US Patent Issued to Bristol-Myers Squibb, Celldex Therapeutics on April 23 for "Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment" (Pennsylvania, Maryland, Connecticut Inventors)
Published: April 24, 2024 by U.S. Fed News
Novartis names former Bristol Myers Squibb CEO Giovanni Caforio as board chairman starting next year; Caforio will replace Joerg Reinhardt, who plans to retire in 2025
Published: April 23, 2024 by BioPharma Dive
Bristol-Myers Squibb Co. Sets Industry Benchmark with Commitments to Environmental Sustainability, Diversity, and Scientific Innovation
Published: April 23, 2024 by Industry Intelligence Inc.
Bristol-Myers Squibb Co. Champions AML Awareness and Diversity in Donor Matching, Highlighting Industry Commitment to Innovation and Equity
Published: April 22, 2024 by Industry Intelligence Inc.
Bristol Myers Squibb enters into a US$380.0M deal with Cellares for the clinical and commercial-scale production of CAR T cell therapies; the companies to use Cellares' Cell Shuttle automated and high-throughput manufacturing platform
Published: April 22, 2024 by Bristol-Myers Squibb Co.

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count